AVXL
Price
$8.36
Change
+$0.06 (+0.72%)
Updated
Dec 13, 04:22 PM (EDT)
55 days until earnings call
MDXG
Price
$9.24
Change
-$0.20 (-2.12%)
Updated
Dec 13, 12:24 PM (EDT)
81 days until earnings call
Ad is loading...

AVXL vs MDXG

Header iconAVXL vs MDXG Comparison
Open Charts AVXL vs MDXGBanner chart's image
Anavex Life Sciences
Price$8.36
Change+$0.06 (+0.72%)
Volume$400
CapitalizationN/A
MiMedx Group
Price$9.24
Change-$0.20 (-2.12%)
Volume$300
CapitalizationN/A
AVXL vs MDXG Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. MDXG commentary
Dec 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and MDXG is a Hold.

COMPARISON
Comparison
Dec 13, 2024
Stock price -- (AVXL: $8.30 vs. MDXG: $9.44)
Brand notoriety: AVXL and MDXG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 56% vs. MDXG: 62%
Market capitalization -- AVXL: $703.8M vs. MDXG: $1.39B
AVXL [@Biotechnology] is valued at $703.8M. MDXG’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $494.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileMDXG’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • MDXG’s FA Score: 1 green, 4 red.
According to our system of comparison, MDXG is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 3 TA indicator(s) are bullish while MDXG’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 3 bullish, 5 bearish.
  • MDXG’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both AVXL and MDXG are a bad buy in the short-term.

Price Growth

AVXL (@Biotechnology) experienced а +9.21% price change this week, while MDXG (@Biotechnology) price change was -0.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.09%. For the same industry, the average monthly price growth was -3.30%, and the average quarterly price growth was +7.38%.

Reported Earning Dates

AVXL is expected to report earnings on Feb 06, 2025.

MDXG is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXG($1.39B) has a higher market cap than AVXL($704M). MDXG YTD gains are higher at: 7.640 vs. AVXL (-10.849). MDXG has higher annual earnings (EBITDA): 66.8M vs. AVXL (-41.47M). AVXL has more cash in the bank: 139M vs. MDXG (88.8M). AVXL has less debt than MDXG: AVXL (88.2K) vs MDXG (19M). MDXG has higher revenues than AVXL: MDXG (343M) vs AVXL (0).
AVXLMDXGAVXL / MDXG
Capitalization704M1.39B51%
EBITDA-41.47M66.8M-62%
Gain YTD-10.8497.640-142%
P/E RatioN/A16.56-
Revenue0343M-
Total Cash139M88.8M157%
Total Debt88.2K19M0%
FUNDAMENTALS RATINGS
AVXL vs MDXG: Fundamental Ratings
AVXL
MDXG
OUTLOOK RATING
1..100
1383
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
7471
SMR RATING
1..100
9612
PRICE GROWTH RATING
1..100
3838
P/E GROWTH RATING
1..100
10076
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVXL's Valuation (54) in the Biotechnology industry is in the same range as MDXG (71). This means that AVXL’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as AVXL (74). This means that MDXG’s stock grew similarly to AVXL’s over the last 12 months.

MDXG's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for AVXL (96). This means that MDXG’s stock grew significantly faster than AVXL’s over the last 12 months.

MDXG's Price Growth Rating (38) in the Biotechnology industry is in the same range as AVXL (38). This means that MDXG’s stock grew similarly to AVXL’s over the last 12 months.

MDXG's P/E Growth Rating (76) in the Biotechnology industry is in the same range as AVXL (100). This means that MDXG’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLMDXG
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBALX52.48-0.33
-0.62%
Columbia Balanced Inst
NWJEX139.39-1.02
-0.73%
Nationwide NYSE Arca Tech 100 Idx R6
RMBTX9.86-0.08
-0.80%
RMB International I
CZMSX17.41-0.17
-0.97%
Multi-Manager Small Cap Eq Strat Inst
ICFAX9.80-0.10
-1.01%
ICON Consumer Select Investor

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with CORT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then CORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+1.47%
CORT - AVXL
56%
Loosely correlated
-6.25%
TENX - AVXL
47%
Loosely correlated
-2.16%
NTLA - AVXL
46%
Loosely correlated
-3.83%
AXON - AVXL
45%
Loosely correlated
-0.94%
PLRX - AVXL
42%
Loosely correlated
-2.46%
More

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-0.21%
AXON - MDXG
47%
Loosely correlated
-0.94%
NTLA - MDXG
45%
Loosely correlated
-3.83%
EDIT - MDXG
42%
Loosely correlated
-5.03%
VCYT - MDXG
42%
Loosely correlated
+2.05%
AVXL - MDXG
41%
Loosely correlated
+1.47%
More